Advertisement

Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study

Published:November 09, 2022DOI:https://doi.org/10.1016/j.dld.2022.10.016

      Abstract

      Background

      Association between Hidradenitis Suppurativa (HS) and Inflammatory Bowel Disease (IBD) has been suggested.

      Aims

      To assess characteristics of HS and IBD in patients with or without concomitant IBD.

      Methods

      In a prospective, nested case-control study, each IBD patient with concomitant HS (Case) was retrospectively matched with 4 patients with HS and no IBD (Controls) for gender and age (±5 years).HS was classified according to the Hurley score and the International Hidradenitis Suppurativa Severity Score System (IHS4). Data were expressed as mean (Standard Deviation). Statistical analysis included Student-t Test or Mann-Whitney Test, χ2 test, univariate and multivariate logistic regression.

      Results

      The study population included 125 patients with HS: 25 with IBD, 100 matched Controls with no IBD. IBD group included 19 (76%) Crohn's disease and 6 (24%) Ulcerative Colitis patients. Obesity, familial HS and perianal HS were less frequent in Cases than in Controls (1[4%] vs 25(25%];p = 0.02; 1[4%] vs 21(21%];p = 0.04; 1[4%] vs 31(31%];p = 0.005, respectively).HS was less severe in Cases when assessed by the IHS4 (5.9 ± 4 vs 9 ± 6.7;p = 0.04).Complete drug-induced response for HS was more frequent in IBD (13[53%] vs28 (28%]; p = 0.04).

      Conclusion

      Clinical characteristics of HS and of patients differed between Cases and Controls. Present findings suggest the need to appropriately search and assess skin lesions compatible with HS in IBD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hanauer S.B.
        Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
        Inflamm Bowel Dis. 2006; 12: 3-9
        • Rogler G.
        • Singh A.
        • Kavanaugh A.
        • et al.
        Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management.
        Gastroenterology. 2021; 161: 1118-1132
        • Lolli E.
        • Saraceno R.
        • Calabrese E.
        • et al.
        Psoriasis phenotype in inflammatory bowel disease: a case-control prospective study.
        J Crohns Colitis. 2015; 9: 699-707
        • Wei-Ti C.
        • Ching-Chi C
        Association of Hidradenitis suppurativa with inflammatory bowel disease a systematic review and meta-analysis.
        JAMA Dermatol. 2019; 155: 1022-1027
        • Principi M.
        • Cassano N.
        • Contaldo A.
        • et al.
        Hydradenitis suppurativa and inflammatory bowel disease: an unusual, but existing association.
        World J Gastroenterol. 2016; 22: 4802-4811
        • Yadav S.
        • Singh S.
        • Varayil J.E.
        • et al.
        Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota.
        Clin Gastroenterol Hepatol. 2016; 14: 65-70
        • Lukach A.J.
        • Saul M.I.
        • Ferris L.K.
        • et al.
        Risk factors for hidradenitis suppurativa in patients with inflammatory bowel disease.
        Dig. Dis. Sci. 2018; 63: 755-760
        • Goldburg S.R.
        • Strober B.E.
        • Payette M.J.
        Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis.
        J Am Acad Dermatol. 2020; 82: 1045-1058
        • Jemec G.B.
        Hidradenitis suppurativa.
        N Engl J Med. 2012; 366: 158-164
        • Campione E.
        • Lanna C.
        • Diluvio L.
        • et al.
        Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
        Cell Cycle. 2020; 19: 257-267
        • Lanna C.
        • Mancini M.
        • Gaziano R.
        • et al.
        Skin immunity and its dysregulation in psoriasis.
        Cell Cycle. 2019; 18: 2581-2589
        • O'Neill C.A.
        • Monteleone G.
        • McLaughlin J.T.
        • et al.
        The gut-skin axis in health and disease: a paradigm with therapeutic implications.
        Bioessays. 2016; 38: 1167-1176
        • Gomollòn F.
        • Dignass A.
        • Annese V.
        • et al.
        ECCO. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management.
        J Crohns Colitis. 2017; 11: 3-25
        • Magro F.
        • Gionchetti P.
        • Eliakim R.
        • et al.
        Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo−anal pouch disorders.
        J Crohns Colitis. 2017; 11: 649-670
        • Satsangi J.
        • Silverberg M.S.
        • Vermeire S.
        • et al.
        The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.
        Gut. 2006; 55: 749-753
        • Hurley H.
        Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach.
        in: Roenigh RRH Roenigk HH Dermatologic surgery. Marcel Dekker, New York1989: 729-739
        • Zouboulis C.C.
        • Tzellos T.
        • Kyrgidis A.
        • et al.
        Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
        Br J Dermatol. 2017; 177: 1401-1409
        • Salvatori S.
        • Marafini I.
        • Monteleone G.
        Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature.
        Eur J Gastroenterol Hepatol. 2021; 33: e1046-e1050
        • Beraldo R.F.
        • Marcondes M.B.
        • Baima J.P.
        • et al.
        Hidradenitis suppurativa as a paradoxical side effect to the use of adalimumab in patients with Crohn's disease?.
        Clin Exp Gastroenterol. 2020; 13: 293-298
        • Deckers I.E.
        • Benhadou F.
        • Koldijk M.J.
        • et al.
        Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study.
        J Am Acad Dermatol. 2017; 76: 49-53
        • Kamal N.
        • Cohen B.L.
        • Buche S.
        • et al.
        Features of patients with Crohn's disease and Hidradenitis suppurativa.
        Clin Gastroenterol Hepatol. 2016; 14: 71-79
        • van der Zee H.H.
        • de Winter K.
        • Van Der Woude C.J.
        • et al.
        The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease.
        Br J Dermatol. 2014; 171: 673-675
        • Pogacnik J.S.
        • Salgado G.
        Perianal Crohn's disease.
        Clin Colon Rectal Surg. 2019; 32: 377-385
        • Jorgensen A.H.R.
        • Thomsen S.F.
        • Karmisholt K.E.
        • et al.
        Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease.
        Exp Dermatol. 2020; 29: 118-123
        • Konig A.
        • Lehmann C.
        • Rompel R.
        • et al.
        Cigarette smoking as a triggering factor of hidradenitis suppurativa.
        Dermatology. 1999; 198: 261-264
        • Piovani D.
        • Danese S.
        • Peyrin-Biroulet L.
        • et al.
        Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses.
        Gastroenterology. 2019; 157: 647-659
        • Smith J.B.
        • Fenske N.A.
        Cutaneous manifestations and consequences of smoking.
        J Am Acad Dermatol. 1996; 34: 717-732
        • Goldburg S.R.
        • Strober B.E.
        • Payette M.J.
        Hidradenitis suppurativa: current and emerging treatments.
        J Am Acad Dermatol. 2020; 82: 1061-1082